159532-37-3

Upstream product

• 1131-01-7 2-chloro-N-(2,6-dimethylphenyl)acetamide 
• 7728-40-7 N-(2,6-dimethylphenyl)-2-ethylaminoacetamide 
• 96-34-4 methyl chloroacetate 
• 87-62-7 2,6-dimethylaniline 

Downstream Products

• 20846-29-1 lidocaine 

Relevant academic research and scientific papers

2, 6 XYLIDINE DERIVATIVES FOR THE TREATMENT OF PAIN

The disclosure herein provides a composition compound of formula 1. The disclosure also provides a method of synthesizing the compound of formula 1. The compound of formula 1 or its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof may be formulated as pharmaceutical composition to be used for treatment of pain. The pharmaceutical composition of compound of formula 1 or the final compound may be formulated for non-invasive peroral, topical (example transdermal), enteral, transmucosal, targeted delivery, sustained release delivery, delayed release, pulsed release and parenteral methods. Such compositions may be used to treat chronic pain manifested with chronic diseases or its associated complications. The compound of formula 1 may also be offered as a kit.